Cardiophase hsCRP Assay
Marking cardiac risk assessment while serving as a biomarker for systematic inflammation
The Cardiophase hsCRP assay is a quantitative analysis test of very low levels of C-reactive protein (CRP) in the blood. The hsCRP assay is being increasingly used as a marker for cardiac risk assessment and as a prognostic tool in heart disease. The CRP test, in addition to lipid evaluation and global risk scoring systems, helps in the evaluation of cardiovascular disease risk in an individual.